Brief: China Resources Pharmaceutical Posts FY Total Operating Revenue For CR Boya Bio-Pharmaceutical
March 13 (Reuters) - China Resources Boya Bio
pharmaceutical Group Co Ltd 300294.SZ :
* FY TOTAL OPERATING REVENUE FOR CR BOYA BIO-PHARMACEUTICAL
RMB2.65 BILLION, DOWN 3.87%
* FY NET PROFIT ATTRIBUTABLE FOR CR BOYA BIO-PHARMACEUTICAL
RMB237.5 MILLION, DOWN 45.06%
Further company coverage: 300294.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million